Fundraising Fox1921 Ventures
Venture capitalVienna · Pre-Seed–Series A · 1 people tracked
Find your way into 1921 Ventures
Sign up to see every warm intro you have to 1921 Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 1921 Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
1921 Ventures invests in early-stage companies tackling Type 1 Diabetes and the diseases that commonly take lives, including cardiovascular, renal, neurodegenerative, and metabolic conditions. The fund backs mission-driven founders building either tech-enabled or biology-driven solutions, with the standard that a company's success should translate into lives saved and meaningful market recognition. It typically provides first money in through select Series A, leading pre-seed and seed rounds and following in later stages. The fund embeds portfolio companies within the global T1D community and vice versa, drawing on a wide network of clinicians, researchers, patients, advocates, and investors. Targeting roughly a €10M fund size, it must deploy at least 70% of capital in the EU.
Source: firm website, verified Oct 2, 2026.
Team · 1 people
from the firm's website
Serial entrepreneur and angel investor who leads 1921, bringing operator experience and networks from his ventures in diabetes care, fintech, and innovation management; his work has reached millions and he focuses the fund on life-changing solutions related to type 1 diabetes.
What they invest in
from 10 of 14 portfolio companiesHealthtech ×6Biotech ×4EdTech ×3Deep Tech ×2Digital Health ×2AI & Machine Learning ×1Climate Tech ×1Enterprise Software ×1
HQs:Austria×2Germany×2Sweden×1
Investments · 14 tracked
founders shown can be your intro pathCharité – Universitätsmedizin Berlin is a university hospital in Germany providing the full range of medical care, from emergency and primary care to highly specialized therapies, prevention, and aftercare, alongside medical research.
BiotechHealthtechBerlin, DE
Diabettech is an information resource about diabetes technology, covering CGM systems, DIY closed-loop insulin delivery, and emerging insulins through blog posts, guides, and user studies.
Digital HealthHealthtechMedia & Entertainment
The Medical University of Graz is a public medical university in southern Austria where staff and students conduct research, teaching, and learning focused on patient health and well-being.
BiotechEdTechHealthtechGraz, AT
The Medical University of Vienna (Medizinische Universität Wien) is a public academic and research institution focused on medicine and the health sciences.
BiotechEdTechHealthtechVienna, AT
hi.health by Pliant is a cashless claims and payments platform for insurers, embedding Visa card-based payments directly into the claims process to enable real-time provider settlement, fraud prevention, and configurable spend controls.
FintechInsurTechSaaS
Co-investorsCalm/Storm VCHaymaker VenturesKinled HoldingSpeedinvest
Personal website of Andreas Klinger, an angel/micro-fund investor who backs early-stage startups across Europe through his fund PROTOTYPE and publishes essays on startups, fundraising, and management.
Sector Agnostic
Andreas Klinger(Investor / Founder of PROTOTYPE)
mySugr is a mobile app for diabetes management that allows users to log blood sugar levels, meals, and activity data, track patterns, and share reports with healthcare providers.
Digital HealthHealthtechWellness & Fitness
Co-investorsHansmann Family OfficePUSH VenturesRoche Venture Fund
NextCell Pharma is a Swedish biotech company developing stem cell therapies (advanced therapy medicinal products) focused primarily on autoimmune and inflammatory diseases, with its lead candidate ProTrans targeting type 1 diabetes.
BiotechDeep TechHealthtech
Norrsken VC is an early-stage venture capital firm investing in technology companies addressing large-scale global challenges across energy, industry, and healthcare.
Climate TechDeep TechImpact & Social Good
Co-investorsKfW CapitalSella Direct Ventures
Pioneers is a management consultancy focused on corporate strategy and innovation, helping large organizations develop new ventures, products, and startup collaborations using startup methods and AI.
AI & Machine LearningEnterprise Software
Professional network for scientists and researchers.
Horst Fickenscher(Founder)Ijad Madisch(Founder)Sören Hofmayer(Founder)
Co-investorsAglae VenturesCapnamicCipio PartnersTenaya CapitalWessel ManagementAccel+2 more
The University of Bayreuth is a German public university focused on research, teaching, and the transfer of knowledge, skills, and technologies.
EdTechBayreuth, DE
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ChildrenwithdiabetesEncotec
Frequently asked questions
- How many investments has 1921 Ventures made?
- 1921 Ventures has 14 tracked investments.
- What stage does 1921 Ventures invest at?
- 1921 Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is 1921 Ventures's typical check size?
- 1921 Ventures typically writes checks of $200K – $1.5M.
- What sectors does 1921 Ventures focus on?
- 1921 Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is 1921 Ventures located?
- 1921 Ventures is headquartered in Vienna, AT.
- Does 1921 Ventures lead rounds?
- Yes, 1921 Ventures leads investment rounds.
- Who does 1921 Ventures co-invest with?
- 1921 Ventures most often shares deals with Aglae Ventures, Capnamic, Roche Venture Fund, among 14 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Golden Seeds is an angel investing network focused on funding and supporting early-stage, U.S.-based women-led startups across most industry sectors, while building a community of investors and providing investor education.